Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Regulatory News
6/19/2024
China Made Advances in Pharma Innovation and Quality: NMPA Official
6/18/2024
CDE Solicits Comments on the Technical Requirements for the Pharmaceut...
6/17/2024
NMPA Announces Package Insert Revision of Cyclophosphamide Adenosine, ...
6/17/2024
CDE Solicits Comments on the Guidelines for Clinical Trial Design of N...
6/17/2024
CDE Issues the List of Reference Formulations for GQCE Studies (81st B...
6/14/2024
CDE Issues the Technical Guidelines for the Assessment of Adverse Even...
6/14/2024
CDE Issues the Dossier Requirements for Marketing Registration Applica...
6/14/2024
CDE Issues Two Pharmaceutical Change Research Guidelines
6/13/2024
CDE Issues the Technical Guidelines for Post-Marketing Pharmaceutical ...
6/12/2024
CDE Issues the Technical Guidelines for Pharmaceutical Research on Com...
6/12/2024
CDE Issues the Technical Guidelines for Pharmaceutical Research of Gen...
6/12/2024
NMPA Issues Revised Blood Product Appendix of Chinese Drug GMP 2010
6/12/2024
NMPA Issues the Technical Guidelines for Electronic Recording of Blood...
6/11/2024
CDE Publicizes the List of Reference Formulations for GQCE Studies (83...
6/7/2024
CDE Solicits Comments on the Guidelines for Pediatric Clinical Trial D...
6/6/2024
FDA Blasts Jiangsu Hengrui for Obstructing Inspection and Manufacturin...
6/3/2024
CDE Solicits Comments on the Guidelines for Evaluating the Pharmacokin...
5/31/2024
CDE Solicits Comments on the Technical Guidelines for the Analysis and...
5/31/2024
China Has Approved 21 Children's Medicines in 2024
5/30/2024
NHC Publicizes the List of Pediatric Drugs Encouraged for R&D and Regi...
5/30/2024
CDE Issues the Technical Guidelines for Application of Decentralized C...
5/28/2024
NMAP Issues the Implementation Suggestions and Chinese Translation of ...
5/28/2024
NMPA Issues Announcement on Pediatric Use Info Addition to the Package...
5/28/2024
NMPA Holds Meeting to Review Vaccine Regulatory QMS
5/24/2024
CDE Solicits Comments on CARE Plan for Rare Disease Drugs
5/23/2024
CDE Issues the List of Reference Formulations for GQCE Studies (80th B...
5/23/2024
NMPA Issues Announcement for Applicability of ICH Guidelines Q5A(R2)
5/21/2024
NMPA and NHC Issue Notice to Strengthen Regulation of Psychotropics In...
5/20/2024
CDE Releases the Annual Report on New Drug Registration Clinical Trial...
5/20/2024
NMPA and South Korean Ministry of Food and Drug Safety Renew MOU for R...
Page:
7
/
8
Total number of articles:
223
:
[First]
[<<]
[4]
[5]
[6]
[7]
[8]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit